Correlation Between Milestone Pharmaceuticals and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Molecular Partners AG, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Molecular Partners.
Diversification Opportunities for Milestone Pharmaceuticals and Molecular Partners
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Milestone and Molecular is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Molecular Partners go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Molecular Partners
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.69 times more return on investment than Molecular Partners. However, Milestone Pharmaceuticals is 1.45 times less risky than Molecular Partners. It trades about 0.28 of its potential returns per unit of risk. Molecular Partners AG is currently generating about -0.06 per unit of risk. If you would invest 143.00 in Milestone Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of 41.00 from holding Milestone Pharmaceuticals or generate 28.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Molecular Partners AG
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Molecular Partners |
Milestone Pharmaceuticals and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Molecular Partners
The main advantage of trading using opposite Milestone Pharmaceuticals and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.The idea behind Milestone Pharmaceuticals and Molecular Partners AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. HCW Biologics | Molecular Partners vs. Scpharmaceuticals | Molecular Partners vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |